Immunopathogenesis of atherosclerosis

Journal of Leukocyte Biology

Volumn 76, Issue 2, 2004, Pages 300-306

  Ludewig, Burkhard ^a   Krebs, Philippe ^a   Scandella, Elke ^a  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

Bystander activation; Immunopathology; Molecular mimicry; Transgenic mouse model

Indexed keywords

AZITHROMYCIN; EPITOPE; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; MACROLIDE; ROXITHROMYCIN; STATINE DERIVATIVE;

ATHEROGENESIS; ATHEROSCLEROSIS; AUTOIMMUNITY; BACTERIUM; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; BYSTANDER EFFECT; CHRONIC INFLAMMATION; CONFERENCE PAPER; DISEASE COURSE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; LYMPHOCYTE ACTIVATION; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMATIC REVIEW; VACCINATION; VIRUS;

ANIMALS; ARTERIOSCLEROSIS; CARDIOVASCULAR SYSTEM; COMMUNICABLE DISEASES; EPITOPES; HUMANS; INFLAMMATION; MOLECULAR MIMICRY;

BACTERIA (MICROORGANISMS); MUS MUSCULUS;

EID: 3442897892     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1203605     Document Type: Conference Paper

References (100)

1. NIH and NHLBI Morbitiy and Mortality: 2002 Chart Book on Cardiovascular, Lung, and Blood Diseases (2003) Bethesda, MD, NHLBI, NIH.
2. Brown, M. S., Goldstein, J. L. (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232, 34-47.
3. Leitersdorf, E., Tobin, E. J., Davignon, J., Hobbs, H. H. (1990) Common low-density lipoprotein receptor mutations in the French Canadian population. J. Clin. Invest. 85, 1014-1023.
4. Plump, A. S., Smith, H. D., Hayek, T., Aalto-Setala, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., Breslow, J. L. (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein-E-deficient mice created by homologous recombination in ES cells. Cell 71, 343-353.
5. Ishibashi, S., Goldstein, J. L., Brown, M. S., Herz, J., Burns, D. K. (1994) Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 93, 1885-1893.
6. Caligiuri, G., Levy, B., Pernow, J., Thoren, P., Hansson, G. K. (1999) Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. Proc. Natl. Acad. Sci. USA 96, 6920-6924.
7. Bruschke, A. V., Kramer Jr., J. R., Bal, E. T., Haque, I. U., Detrano, R. C., Goormastic, M. (1989) The dynamics of progression of coronary atherosclerosis studied in 168 medically treated patients who underwent coronary arteriography three times. Am. Heart J. 117, 296-305.
8. Pesonen, E., Paakkari, I., Rapola, J. (1999) Infection-associated intimal thickening in the coronary arteries of children. Atherosclerosis 142, 425-429.
9. Ridker, P. M., Hennekens, C. H., Buring, J. E., Rifai, N. (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342, 836-843.
10. Malik, I., Danesh, J., Whincup, P., Bhatia, V., Papacosta, O., Walker, M., Lennon, L., Thomson, A., Haskard, D. (2001) Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet 358, 971-976.
11. Epstein, S. E., Zhu, J., Burnett, M. S., Zhou, Y. F., Vercellotti, G., Hajjar, D. (2000) Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler. Thromb. Vasc. Biol. 20, 1417-1420.
12. Espinola-Klein, C., Rupprecht, H. J., Blankenberg, S., Bickel, C., Kopp, H., Rippin, G., Victor, A., Hafner, G., Schlumberger, W., Meyer, J. (2002) Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 105, 15-21.
13. Georges, J. L., Rupprecht, H. J., Blankenberg, S., Poirier, O., Bickel, C., Hafner, G., Nicaud, V., Meyer, J., Cambien, F., Tiret, L. (2003) Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. Am. J. Cardiol. 92, 515-521.
14. Huittinen, T., Leinonen, M., Tenkanen, L., Virkkunen, H., Manttari, M., Palosuo, T., Manninen, V., Saikku, P. (2003) Synergistic effect of persistent Chlamydia pneumoniae infection, autoimmunity, and inflammation on coronary risk. Circulation 107, 2566-2570.
15. Sriram, S., Stratton, C. W., Yao, S., Tharp, A., Ding, L., Bannan, J. D., Mitchell, W. M. (1999) Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann. Neurol. 46, 6-14.
16. Balin, B. J., Gerard, H. C., Arking, E. J., Appelt, D. M., Branigan, P. J., Abrams, J. T., Whittum-Hudson, J. A., Hudson, A. P. (1998) Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med. Microbiol. Immunol. (Berl.) 187, 23-42.
17. Gaydos, C. A., Summersgill, J. T., Sahney, N. N., Ramirez, J. A., Quinn, T. C. (1996) Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect. Immun. 64, 1614-1620.
18. Chiu, B., Viira, E., Tucker, W., Fong, I. W. (1997) Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 96, 2144-2148.
19. Maass, M., Bartels, C., Engel, P. M., Mamat, U., Sievers, H. H. (1998) Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary, artery disease. J. Am. Coll. Cardiol. 31, 827-832.
20. Coombes, B. K., Mahony, J. B. (1999) Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s). Infect. Immun. 67, 2909-2915.
21. Kalayoglu, M. V., Hoememan, B., LaVerda, D., Morrison, S. G., Morrison, R. P., Byrne, G. I. (1999) Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae. J. Infect. Dis. 180, 780-790.
22. Saikku, P., Leinonen, M., Mattila, K., Ekman, M. R., Nieminen, M. S., Makela, P. H., Huttunen, J. K., Valtonen, V. (1988) Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2, 983-986.
23. Danesh, J., Whincup, P., Walker, M., Lennon, L., Thomson, A., Appleby, P., Wong, Y., Bernardes-Silva, M., Ward, M. (2000) Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ 321, 208-213.
24. Danesh, J., Whincup, P., Lewington, S., Walker, M., Lennon, L., Thomson, A., Wong, Y. K., Zhou, X., Ward, M. (2002) Chlamydia pneumoniae IgA titres and coronary heart disease; prospective study and meta-analysis. Eur. Heart J. 23, 371-375.
25. Bartels, C., Maass, M., Bein, G., Brill, N., Bechtel, J. F., Leyh, R., Sievers, H. H. (2000) Association of serology with the endovascular presence of Chlamydia pneumoniae and cytomegalovirus in coronary artery and vein graft disease. Circulation 101, 137-141.
26. Vink, A., Poppen, M., Schoneveld, A. H., Roholl, P. J., de Kleijn, D. P., Borst, C., Pasterkamp, G. (2001) Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual. Circulation 103, 1613-1617.
27. Smieja, M., Mahony, J., Petrich, A., Boman, J., Chernesky, M. (2002) Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review. BMC Infect. Dis. 2, 21.
28. Ameriso, S. F., Fridman, E. A., Leiguarda, R. C., Sevlever, G. E. (2001) Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 32, 385-391.
29. Danesh, J., Peto, R. (1998) Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 316, 1130-1132.
30. Pietroiusti, A., Diomedi, M., Silvestrini, M., Cupini, L. M., Luzzi, I., Gomez-Miguel, M. J., Bergamaschi, A., Magrini, A., Carrabs, T., Vellini, M., Galante, A. (2002) Cytotoxin-associated gene-A-positive Helicobacter pylori strains are associated with atherosclerotic stroke. Circulation 106, 580-584.
31. Mayr, M., Kiechl, S., Mendall, M. A., Willeit, J., Wick, G., Xu, Q. (2003) Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: prospective results from the Bruneck study. Stroke 34, 610-615.
32. Fabricant, C. G., Fabricant, J., Litrenta, M. M., Minick, C. R. (1978) Virus-induced atherosclerosis. J. Exp. Med. 148, 335-340.
33. Fabricant, C. G., Fabricant, J. (1999) Atherosclerosis induced by infection with Marek's disease herpesvirus in chickens. Am. Heart J. 138, S465-S468.
34. O'Toole, D., Li, H., Roberts, S., Rovnak, J., DeMartini, J., Cavender, J., Williams, B., Crawford, T. (1995) Chronic generalized obliterative arteriopathy in cattle: a sequel to sheep-associated malignant catarrhal fever. J. Vet. Diagn. Invest. 7, 108-121.
35. Murakami, K., Ohsawa, M., Hu, S. X., Kanno, H., Aozasa, K., Nose, M. (1998) Large-vessel arteritis associated with chronic active Epstein-Barr virus infection. Arthritis Rheum. 41, 369-373.
36. Adam, E., Melnick, J. L., Probtsfield, J. L., Petrie, B. L., Burek, J., Bailey, K. R., McCollum, C. H., DeBakey, M. E. (1987) High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 2, 291-293.
37. Zhou, Y. F., Leon, M. B., Waclawiw, M. A., Popma, J. J., Yu, Z. X., Finkel, T., Epstein, S. E. (1996) Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N. Engl. J. Med. 335, 624-630.
38. Yonemitsu, Y., Nakagawa, K., Tanaka, S., Mori, R., Sugimachi, K., Sueishi, K. (1996) In situ detection of frequent and active infection of human cytomegalovirus in inflammatory abdominal aortic aneurysms: possible pathogenic role in sustained chronic inflammatory reaction. Lab. Invest. 74, 723-736.
39. Hendrix, M. G., Salimans, M. M., van Boven, C. P., Bruggeman, C. A. (1990) High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am. J. Pathol. 136, 23-28.
40. Grahame-Clarke, C., Chan, N. N., Andrew, D., Ridgway, G. L., Betteridge, D. J., Emery. V., Colhoun, H. M., Vallance, P. (2003) Human cytomegalovirus seropositivity is associated with impaired vascular function. Circulation 108, 678-683.
41. Jarvis, M. A., Nelson, J. A. (2002) Human cytomegalovirus persistence and latency in endothelial cells and macrophages. Curr. Opin. Microbiol. 5, 403-407.
42. Speir, E. (2000) Cytomegalovirus gene regulation by reactive oxygen species. Agents in atherosclerosis. Ann. N. Y. Acad. Sci. 899, 363-374.
43. Streblow, D. N., Soderberg-Naucler, C., Vieira, J., Smith, P., Wakabayashi, E., Ruchti, F., Mattison, K., Altschuler, Y., Nelson, J. A. (1999) The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 99, 511-520.
44. Dansky, H. M., Charlton, S. A., Harper, M. M., Smith, J. D. (1997) T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA 94, 4642-4646.
45. Daugherty, A., Pure, E., Delfel-Butteiger, D., Chen, S., Leferovich, J., Roselaar, S. E., Rader, D. J. (1997) The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. J. Clin. Invest. 100, 1575-1580.
46. Song, L., Leung, C., Schindler, C. (2001) Lymphocytes are important in early atherosclerosis. J. Clin. Invest. 108, 251-259.
47. Zhou, X., Nicoletti, A., Elhage, R., Hansson, G. K. (2000) Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 102, 2919-2922.
48. Gupta, S., Pablo, A. M., Jiang, X. C., Wang, N., Tall, A. R., Schindler, C. (1997) IFN-γ potentiates atherosclerosis in ApoE knock-out mice. J. Clin. Invest. 99, 2752-2761.
49. Mach, F., Schonbeck, U., Sukhova, G. K., Atkinson, E., Libby, P. (1998) Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394, 200-203.
50. Burnett, M. S., Gaydos, C. A., Madico, G. E., Glad, S. M., Paigen, B., Quinn, T. C., Epstein, S. E. (2001) Atherosclerosis in apoE knockout mice infected with multiple pathogens. J. Infect. Dis. 183, 226-231.
51. Alber, D. G., Powell, K. L., Vallance, P., Goodwin, D. A., Grahame-Clarke, C. (2000) Herpesvirus infection accelerates atherosclerosis in the apolipoprotein E-deficient mouse. Circulation 102, 779-785.
52. Alber, D. G., Vallance, P., Powell, K. L. (2002) Enhanced atherogenesis is not an obligatory response to systemic herpesvirus infection in the apoE-deficient mouse: comparison of murine γ-herpesvirus-68 and herpes simplex virus-1. Arterioscler. Thromb. Vasc. Biol. 22, 793-798.
53. Hu, H., Pierce, G. N., Zhong, G. (1999) The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J. Clin. Invest. 103, 747-753.
54. Moazed, T. C., Campbell, L. A., Rosenfeld, M. E., Grayston, J. T., Kuo, C. C. (1999) Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J. Infect. Dis. 180, 238-241.
55. Rothstein, N. M., Quinn, T. C., Madico, G., Gaydos, C. A., Lowenstein, C. J. (2001) Effect of azithromyein on murine arteriosclerosis exacerbated by Chlamydia pneumoniae. J. Infect. Dis. 183, 232-238.
56. Caligiuri, G., Rottenberg, M., Nicoletti, A., Wigzell, H., Hansson, G. K. (2001) Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice. Circulation 103, 2834-2838.
57. Leinonen, M., Saikku, P. (2002) Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect. Dis. 2, 11-17.
58. Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., Rollins, B. J. (1998) Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell 2, 275-281.
59. Dong, Z. M., Chapman, S. M., Brown, A. A., Frenette, P. S., Hynes, R. O., Wagner, D. D. (1998) The combined role of P- and E-selectins in atherosclerosis. J. Clin. Invest. 102, 145-152.
60. Wright, S. D., Burton, C., Hernandez, M., Hassing, H., Montenegro, J., Mundt, S., Patel, S., Card, D. J., Hermanowski-Vosatka, A., Bergstrom, J. D., Sparrow, C. P., Detmers, P. A., Chao, Y. S. (2000) Infectious agents are not necessary for marine atherogenesis. J. Exp. Med. 191, 1437-1442.
61. Karrer, U., Althage, A., Odermatt, B., Roberts, C. W., Korsmeyer, S. J., Miyawaki, S., Hengartner, H., Zinkernagel, R. M. (1997) On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (Hox11(-/-)) mutant mice. J. Exp. Med. 185, 2157-2170.
62. Oldstone, M. B. (1987) Molecular mimicry and autoimmune disease. Cell 50, 819-820.
63. Kol, A., Sukhova, G. K., Lichtman, A. H., Libby, P. (1998) Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-α and matrix metalloproteinase expression. Circulation 98, 300-307.
64. George, J., Shoenfeld, Y., Afek, A., Gilburd, B., Keren, P., Shaish, A., Kopolovic, J., Wick, G., Harats, D. (1999) Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65. Arterioscler. Thromb. Vase. Biol. 19, 505-510.
65. George, J., Afek, A., Gilburd, B., Shoenfeld, Y., Harats, D. (2001) Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice. J. Am. Coll. Cardiol. 38, 900-905.
66. Mayr, M., Kiechl, S., Willeit, J., Wick, G., Xu, Q. (2000) Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 102, 833-839.
67. Mayr, M., Metzler, B., Kiechl, S., Willeit, J., Schett, G., Xu, Q., Wick, G. (1999) Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation 99, 1560-1566.
68. Xu, Q., Kleindienst, R., Waitz, W., Dietrich, H., Wick, G. (1993) Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. J. Clin. Invest. 91, 2693-2702.
69. Moessler, H., Mericskay, M., Li, Z., Nagl, S., Paulin, D., Small, J. V. (1996) The SM 22 promotor directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice. Development 122, 2415-2425.
70. Ludewig, B., Ochsenbein, A. F., Odermatt, B., Paulin, D., Hengartner, H., Zinkernagel, R. M. (2000) Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease. J. Exp. Med. 191, 795-804.
71. Ludewig, B., Freigang, S., Jaggi, M., Kurrer, M. O., Pei, Y. C., Vlk, L., Odermatt, B., Zinkernagel, R. M., Hengartner, H. (2000) Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model. Proc. Natl. Acad. Sci. USA 97, 12752-12757.
72. Zhou, X., Paulsson, G., Stemme, S., Hansson, G. K. (1998) Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J. Clin. Invest. 101, 1717-1725.
73. Blessing, E., Campbell, L. A., Rosenfeld, M. E., Chough, N., Kuo, C. (2001) Chlamydia pneumoniae infection accelerates hyperlipidemia-induced atherosclerotic lesion development in C57BL/6J mice. Atherosclerosis 158, 13-17.
74. Vanderlugt, C. L., Miller, S. D. (2002) Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat. Rev. Immunol. 2, 85-95.
75. Miller, S. D., Vanderlugt, C. L., Begolka, W. S., Pao, W., Yauch, R. L., Neville, K. L., Katz-Levy, Y., Carrizosa, A., Kim, B. S. (1997) Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3, 1133-1136.
76. Xu, Q. (2003) Infections, heat shock proteins, and atherosclerosis. Curr. Opin. Cardiol. 18, 245-252.
77. Binder, C. J., Chang, M. K., Shaw, P. X., Miller, Y. I., Hartvigsen, K., Dewan, A., Witztum, J. L. (2002) Innate and acquired immunity in atherogenesis. Nat. Med. 8, 1218-1226.
78. Yla-Herttuala, S., Palinski, W., Rosenfeld, M. E., Parthasarathy, S., Carew, T. E., Butler, S., Witztum, J. L., Steinberg, D. (1989) Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84, 1086-1095.
79. Yla-Herttuala, S., Palinski, W., Butler, S. W., Picard, S., Steinberg, D., Witztum, J. L. (1994) Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler. Thromb. 14, 32-40.
80. Virella, G., Atchley, D., Koskinen, S., Zheng, D., Lopes-Virella, M. F. (2002) Proatherogenic and proinflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL. Clin. Immunol. 105, 81-92.
81. Freigang, S., Horkko, S., Miller, E., Witztum, J. L., Palinski, W. (1998) Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioseler. Thromb. Vasc. Biol. 18, 1972-1982.
82. Palinski, W., Miller, E., Witztum, J. L. (1995) Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc. Natl. Acad. Sci. USA 92, 821-825.
83. Stemme, S., Faber, B., Holm, J., Wiklund, O., Witztum, J. L., Hansson, G. K. (1995) T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA 92, 3893-3897.
84. Fabricant, C. G., Hajjar, D. P., Minick, C. R., Fabricant, J. (1981) Herpesvirus infection enhances cholesterol and cholesteryl ester accumulation in cultured arterial smooth muscle cells. Am. J. Pathol. 105, 176-184.
85. Berencsi, K., Endresz, V., Klurfeld, D., Kari, L., Kritchevsky, D., Gonczol, E. (1998) Early atherosclerotic plaques in the aorta following cytomegalovirus infection of mice. Cell Adhes. Commun. 5, 39-47.
86. Horwitz, M. S., Bradley, L. M., Harbertson, J., Krahl, T., Lee, J., Sarvetnick, N. (1998) Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat. Med. 4, 781-785.
87. Selzman, C. H., Netea, M. G., Zimmerman, M. A., Weinberg, A., Reznikov, L. L., Grover, F. L., Dinarello, C. A. (2003) Atherogenic effects of Chlamydia pneumoniae: refuting the innocent bystander hypothesis. J. Thorac. Cardiovasc. Surg. 126, 688-693.
88. Netea, M. G., Kullberg, B. J., Galama, J. M., Stalenhoef, A. F., Dinarello, C. A., van der Meer, J. W. (2002) Non-LPS components of Chlamydia pneumoniae stimulate cytokine production through Toll-like receptor 2-dependent pathways. Eur. J. Immunol. 32, 1188-1195.
89. Froberg, M. K., Adams, A., Seacotte, N., Parker-Thornburg, J., Kolattukudy, P. (2001) Cytomegalovirus infection accelerates inflammation in vascular tissue overexpressing monocyte chemoattractant protein-1. Circ. Res. 89, 1224-1230.
90. Veillard, N. R., Mach, F. (2002) Statins: the new aspirin? Cell. Mol. Life Sci. 59, 1771-1786.
91. Kwak, B., Mulhaupt, F., Myit, S., Mach, F. (2000) Statins as a newly recognized type of immunomodulator. Nat. Med. 6, 1399-1402.
92. Fong, I. W., Chiu, B., Viira, E., Jang, D., Mahony, J. B. (2002) Influence of clarithromycin on early atherosclerotic lesions after Chlamydia pneumoniae infection in a rabbit model. Antimicrob. Agents Chemother. 46, 2321-2326.
93. Sander, D., Winbeck, K., Klingelhofer, J., Etgen, T., Conrad, B. (2002) Reduced progression of early carotid atherosclerosis after antibiotic treatment and Chlamydia pneumoniae seropositivity. Circulation 106, 2428-2433.
94. Parchure, N., Zouridakis, E. G., Kaski, J. C. (2002) Effect of azithromycin treatment on endothelial function in patients with coronary artery disease and evidence of Chlamydia pneumoniae infection. Circulation 105, 1298-1303.
95. Stone, A. F., Mendall, M. A., Kaski, J. C., Edger, T. M., Risley, P., Poloniecki, J., Camm, A. J., Northfield, T. C. (2002) Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA). Circulation 106, 1219-1223.
96. Sinisalo, J., Mattila, K., Valtonen, V., Anttonen, O., Juvonen, J., Melin, J., Vuorinen-Markkola, H., Nieminen, M. S. (2002) Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-q-wave coronary syndrome. Circulation 105, 1555-1560.
97. O'Connor, C. M., Dunne, M. W., Pfeffer, M. A., Muhlestein, J. B., Yao, L., Gupta, S., Benner, R. J., Fisher, M. R., Cook, T. D. (2003) Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. JAMA 290, 1459-1466.
98. Murdin, A. D., Dunn, P., Sodoyer, R., Wang, J., Caterini, J., Brunham, R. C., Aujame, L., Oomen, R. (2000) Use of a mouse lung challenge model to identify antigens protective against Chlamydia pneumoniae lung infection. J. Infect. Dis. 181 (Suppl. 3), S544-S551.
99. Zhou, X., Caligiuri, G., Hamsten, A., Lefvert, A. K., Hansson, G. K. (2001) LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21, 108-114.
100. Maron, R., Sukhova, G., Faria, A. M., Hoffmann, E., Mach, F., Libby, P., Weiner, H. L. (2002) Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation 106, 1708-1715.